Glucose News and Research

RSS

Roundup: NY Times on mental health cuts; Wis. GOP agenda moves ahead; Minn. Medicaid expansion

Gov. Mark Dayton said during his campaign that enrolling 95,000 people in an expanded Medicaid program would be his top priority when he took office -- and he meant it. Less than three weeks after he was told by members of former Gov. Tim Pawlenty's administration that it could take until October to enact the change, Dayton announced Thursday that it would be done by March 1.

21 Jan 2011

MedImmune announces MEDI-573 preclinical results against many solid tumors

MedImmune's Oncology group announced today preclinical results showing that MEDI-573, a targeted monoclonal antibody, broadly suppresses pathways that have been shown to play a critical role in the development and progression of many solid tumors.

21 Jan 2011

HIV-infected patients three times more likely to suffer strokes

While the overall hospitalization rate for stroke has declined in recent years, the numbers have jumped dramatically for patients infected with human immunodeficiency virus (HIV), suggesting they may be up to three times more likely to suffer a stroke than people uninfected by the virus that causes AIDS.

20 Jan 2011

CJPS Medical Systems to launch VitalPoint Remote Patient Monitor in the U.K.

CJPS Medical Systems are launching into the U.K. market this week their VitalPoint® Remote Patient Monitor, a medical device capable of measuring patients' vital signs from home, allowing secure and direct communication with their caregiver, creating electronic medical records, and transmitting vital signs data.

19 Jan 2011

Three-stage approach to fMRI could improve detection of neural activity

Over the last few years, researchers have used a type of brain scanning, known as functional magnetic resonance imaging fMRI, to help them map changes in blood flow in the brain and to correlate this with thoughts and behavior. A new way to analyze fMRI data, which could improve is reported in the International Journal of Computational Biology and Drug Design.

19 Jan 2011

PositiveID and RFID Solutions complete development of temperature-sensing microchip

PositiveID Corporation announced today that it has completed the development of its temperature-sensing microchip in conjunction with development partner RFID Solutions of Malaga, Spain. The microchip, which uses radio frequency identification (RFID) technology, is able to measure internal temperature within the body and communicate that temperature wirelessly to an external reader.

18 Jan 2011

Health Canada approves Eli Lilly's BYETTA for treatment of adults with type 2 diabetes

Eli Lilly Canada is pleased to announce the Health Canada approval of BYETTATM for the treatment of adults with type 2 diabetes.

18 Jan 2011

Infant macrosomia is a risk factor for postneonatal death among First Nations

High birth weight in First Nations babies are linked to a higher risk of postneonatal death, according to a study published in CMAJ.

18 Jan 2011

First Round Table Meeting on Metabolomics & Diabetes takes place in Vienna

Metabolomic biomarker research is a young research area that carries great hopes for both medicine and the nutritional sciences, particularly for the early detection of genetically determined diseases.

14 Jan 2011

Unintended direct conflict between pharmaceutical marketing and public health

Drugs that pharmaceutical companies market most aggressively to physicians and patients tend to offer less benefit and more harm to most patients - a phenomenon described as the "inverse benefit law" in a paper from the University of Texas Medical Branch at Galveston.

14 Jan 2011

Researchers discover molecular mechanism behind coffee's protective effect

Coffee, that morning elixir, may give us an early jump-start to the day, but numerous studies have shown that it also may be protective against type 2 diabetes. Yet no one has really understood why.

14 Jan 2011

Exposure to room light prior to bedtime suppresses melatonin levels, increases cancer and diabetes risk: Study

According to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism, exposure to electrical light between dusk and bedtime strongly suppresses melatonin levels and may impact physiologic processes regulated by melatonin signaling, such as sleepiness, thermoregulation, blood pressure and glucose homeostasis.

13 Jan 2011

Researchers launch estrogen therapy trial to study depression, cardiovascular illness in women

Researchers at the University of North Carolina at Chapel Hill have launched a new clinical trial to determine if estrogen replacement therapy may help prevent depression and cardiovascular illness in women between the ages of 45 and 55.

13 Jan 2011

Study highlights important clinical implications of miR-503 in diabetes-associated vascular complications

New research has found one of the smallest entities in the human genome, micro-RNA, could increase the risk of limb amputation in diabetic patients who have poor blood flow.

13 Jan 2011

Plenty of breaks from sitting at the desk are good for hearts and waistlines: Study

It is becoming well accepted that, as well as too little exercise, too much sitting is bad for people's health. Now a new study has found that it is not just the length of time people spend sitting down that can make a difference, but also the number of breaks that they take while sitting at their desk or on their sofa. Plenty of breaks, even if they are as little as one minute, seem to be good for people's hearts and their waistlines.

12 Jan 2011

Eli Lilly, Boehringer Ingelheim enter global agreement to develop and commercialize diabetes compounds

Boehringer Ingelheim and Eli Lilly and Company today announced a global agreement to jointly develop and commercialize a portfolio of diabetes compounds currently in mid- and late-stage development.

12 Jan 2011

FDA accepts Merck's JANUMET extended-release formulation NDA for type 2 diabetes

Merck today announced that the New Drug Application (NDA) for the Company's investigational extended-release formulation of JANUMET for type 2 diabetes has been accepted for standard review by the U.S. Food and Drug Administration (FDA). The Company is also moving forward as planned with regulatory filings in countries outside the United States.

12 Jan 2011

Lilly and Boehringer Ingelheim enter global agreement to develop and commercialize diabetes compounds

Eli Lilly and Company and Boehringer Ingelheim today announced a global agreement to jointly develop and commercialize a portfolio of diabetes compounds currently in mid- and late-stage development.

11 Jan 2011

Study: Protein that plays a key role in some antioxidant therapies can promote atherosclerosis

UCLA researchers have found that a protein that plays an important role in some antioxidant therapies may not be as effective due to additional mechanisms that cause it to promote atherosclerosis, or clogging of the arteries.

11 Jan 2011

FDA approved KOMBIGLYZE XR for type 2 diabetes mellitus now available in pharmacies

Bristol-Myers Squibb Company, and AstraZeneca today announced that KOMBIGLYZE™ XR (saxagliptin and metformin HCl extended-release), approved by the U.S. Food and Drug Administration (FDA) on November 5, 2010, is now available by prescription in pharmacies across the United States.

7 Jan 2011

Glucose News and Research

Roundup: NY Times on mental health cuts; Wis. GOP agenda moves ahead; Minn. Medicaid expansion

MedImmune announces MEDI-573 preclinical results against many solid tumors

HIV-infected patients three times more likely to suffer strokes

CJPS Medical Systems to launch VitalPoint Remote Patient Monitor in the U.K.

Three-stage approach to fMRI could improve detection of neural activity

PositiveID and RFID Solutions complete development of temperature-sensing microchip

Health Canada approves Eli Lilly's BYETTA for treatment of adults with type 2 diabetes

Infant macrosomia is a risk factor for postneonatal death among First Nations

First Round Table Meeting on Metabolomics & Diabetes takes place in Vienna

Unintended direct conflict between pharmaceutical marketing and public health

Researchers discover molecular mechanism behind coffee's protective effect

Exposure to room light prior to bedtime suppresses melatonin levels, increases cancer and diabetes risk: Study

Researchers launch estrogen therapy trial to study depression, cardiovascular illness in women

Study highlights important clinical implications of miR-503 in diabetes-associated vascular complications

Plenty of breaks from sitting at the desk are good for hearts and waistlines: Study

Eli Lilly, Boehringer Ingelheim enter global agreement to develop and commercialize diabetes compounds

FDA accepts Merck's JANUMET extended-release formulation NDA for type 2 diabetes

Lilly and Boehringer Ingelheim enter global agreement to develop and commercialize diabetes compounds

Study: Protein that plays a key role in some antioxidant therapies can promote atherosclerosis

FDA approved KOMBIGLYZE XR for type 2 diabetes mellitus now available in pharmacies

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News